Abstract: Polymeric stents having fracture toughness and resistance to recoil after deployment are disclosed along with methods of manufacturing such stents. Improvements to mechanical characteristics and other improvements may be achieved by having polymer chains within individual stent struts oriented in a direction that is closer to or in line with the axis of the individual stent struts. The struts are connected to each other by hinge elements that are configured to bend during crimping and deployment of the stent. The hinge elements may be tangent or non-tangent to the adjoining struts so as to form W-shaped closed cells arranged in an offset brick pattern in which the size each W-shaped closed cell can be defined in part by a curvilinear length that is approximately 4.5 mm, which allows the stent to be crimped down to an OD of about 1.3 mm and expanded to an OD of at least about 3.5 mm.
Type:
Grant
Filed:
July 7, 2010
Date of Patent:
November 6, 2012
Assignee:
Abbott Cardiovascular Systems Inc.
Inventors:
Brenna Hearn Lord, Nicole F. Hou, Timothy A. Limon
Abstract: Provided is a power system capable of supplying power steadily to the outside even at a low temperature. A power supply unit disposed in the power system is configured to calculate an amount of power needed to heat a fuel cell to a temperature threshold when the temperature thereof measured by an FC sensor is below the temperature threshold, set an SOC lower limit by adding the calculated amount of power to a discharge threshold of a secondary battery, and control the power supply to a first power supply portion in the range of the SOC lower limit.
Abstract: The invention proposes a method for transmitting a message to a plurality of user entities in a network by using a multicast service, comprising the steps of encrypting a multicast message by using ciphering, and sending the encrypted multicast message to the plurality of user entities simultaneously. The invention also proposes a corresponding multicast service control device and a corresponding user entity.
Abstract: A fastening body structure having a screw member which uses a module screw having a countersunk head and a washer made of a shape memory alloy. With this structure, the washer does not expand even if subjected to large fastening force and the washer can be easily removed when the screw fastening is released. The fastening body structure fastens and fixes a desired part to the installation section by using the screw member having the module screw and the washer. The module screw has a male screw used as a pair with a female screw thread section formed in the installation section. The washer has an inner diameter corresponding to the module screw. An irregular surface section is formed on a slope surface at the lower part of the head of the module screw or on the surface of the washer that makes contact with the screw.
Abstract: A stent for delivery of a therapeutic agent is disclosed. The stent includes a polymer coating for reducing the rate of release of the therapeutic agent. The polymer has a crystalline structure wherein the polymer is capable of significantly maintaining the crystalline lattice structure while the therapeutic agent is released from the stent such that the aqueous environment to which the stent is exposed subsequent to the implantation of the stent does not significantly convert the crystalline lattice structure of the polymer to an amorphous structure.
Abstract: A start permission decision section issues a start permission when an engine speed and a throttle valve opening become higher than predetermined values. A clutch-torque capacity storage section stores a clutch-torque capacity reference map in which a clutch-torque capacity is set as a function of at least the engine speed or as a function of the engine speed and the throttle valve opening. A clutch-torque capacity correction section corrects the clutch-torque capacity reference map so that the clutch-torque capacity is proportionally reduced in response to the difference between the engine speed and a start permission speed when a start permission is issued. An oil pressure controlling section connects the clutch with the clutch-torque capacity obtained in accordance with the corrected clutch-torque capacity map to start the vehicle.
Abstract: The present invention relates generally to ultradispersed catalyst compositions and methods for preparing such catalysts. In particular, the invention provides catalyst composition of the general formula: BxMyS[(1.1 to 4.6)y+(0.5 to 4)x] where B is a group VIIIB non-noble metal and M is a group VI B metal and 0.05?y/x?15.
Type:
Grant
Filed:
January 10, 2011
Date of Patent:
November 6, 2012
Assignee:
University of Calgary
Inventors:
Pedro Pereira-Almao, Vieman Alberto Ali-Marcano, Francisco Lopez-Linares, Alejandro Vasquez
Abstract: Methods of and systems for fabricating a polymeric stent with improved fracture toughness including radial expansion of a polymer tube along its entire length at the same time and fabricating a stent from the expanded tube are disclosed herein.
Type:
Grant
Filed:
July 27, 2011
Date of Patent:
November 6, 2012
Assignee:
Abbott Cardiovascular Systems Inc.
Inventors:
Lothar W. Kleiner, James P. Oberhauser, Thierry Glauser, David K. Wrolstad, Yunbing Wang
Abstract: A throttle opening detection apparatus can include a throttle pipe, a throttle sensor, a resisting force application unit, and a cancel switch. The throttle pipe is configured to partly project into a case fixed to a bar handle and is configured to support rotation at an end portion of the bar handle. The throttle sensor is configured to detect a rotating operation amount of a throttle grip, which is mounted against relative rotation on the throttle pipe, in response to the rotation of the throttle pipe. The throttle sensor is disposed at a fixed position in the case. The resisting force application unit is configured to apply a resisting force to the rotating operation of the throttle grip. The resisting force application unit is accommodated in the case. The cancel switch configured to cancel operation of an auto-cruise controlling apparatus. The cancel switch is accommodated in the case together with the throttle sensor and the resisting force application unit.
Abstract: This invention relates to the identification of variants of an organism using variant-specific oligonucleotide primer pools to specifically hybridize to those polynucleotides in an sample comprising a plurality of polynucleotides that contain a target sequence that is unambiguously identifiable with a particular variant of the organism.
Abstract: An apparatus is provided that includes a processor and a memory. The processor is configured to determine a category for a group of isolated noun phrases in a structured or semi-structured data source stored in the memory. The group of isolated noun phrases includes one or more isolated noun phrases. The processor is also configured to translate the group of isolated noun phrases from a source language to a target language using a category-driven isolated noun phrase translation. The determination of the category and the category-driven isolated noun phrase translation are performed based on context derived from the group of isolated noun phrases.
Type:
Grant
Filed:
August 17, 2009
Date of Patent:
November 6, 2012
Assignee:
N T repid Corporation
Inventors:
Linda C. Van Guilder, Jennifer B. Doyon, Michael E. Martinka, Jon B. Phillips, Kristian J. Concepcion, Robert C. Muir
Abstract: A set of bolt holes through which bolts are inserted are formed in left and right sides of a large end section. The bolt holes are substantially parallel to the axis of a rod section and are located such that the centers of the bolt holes are each displaced from the center of a cut surface. When a first mandrel and a second mandrel are press fitted to a joint hole of the large end section and are cut and split, the area of contact of the second mandrel on the movable stage side with the inner wall of the joint hole is set greater than the area of contact of the first mandrel on the fixed stage side with the inner wall of the joint hole.
Abstract: The Exemplary embodiments of the invention provide at least a method, apparatus, and computer program for signaling parameters to at least one network node in a communications network. In accordance with the exemplary embodiments, the signaling is performed by operations that include, signaling a first parameter A, and jointly signaling, to the at least one network node in the communications network, a second parameter B and a third parameter C. In addition, the exemplary embodiments of the invention provide at least a method, apparatus, and computer program for receiving parameters from at least one network node in a communications network by operations that include receiving signaling comprising a first parameter A and joint signaling indicating a second parameter B and a third parameter C, and extracting the parameters from the received signaling.
Abstract: The present invention relates generally to ultradispersed catalyst compositions and methods for preparing such catalysts. In particular, the invention provides catalyst composition of the general formula: BxMyS[(1.1 to 4.6)y+(0.5 to 4)x] where B is a group VIIIB non-noble metal and M is a group VI B metal and 0.05?y/x?15.
Type:
Grant
Filed:
January 10, 2011
Date of Patent:
October 30, 2012
Assignee:
University of Calgary
Inventors:
Pedro Pereira-Almao, Vieman Alberto Ali-Marcano, Francisco Lopez-Linares, Alejandro Vasquez
Abstract: Medical articles with porous polymeric structures and methods of forming thereof are disclosed. The porous structure can have pores sizes that are nanoporous or greater than nanoporous. The porous structure can be a coating or layer of a medical device such as a stent, stent graft, catheter, or lead for pacemakers or implantable cardioverter defibrillators. Additionally, the body of the medical device can be a porous polymeric structure. The porous structure can be made from bioabsorbable polymers. The porous structures can be formed by contacting a polymer with a supercritical fluid.
Abstract: A method to control cell selection and/or re-selection in a communication system comprising a plurality of cells with which terminal devices may communicate, the method including the steps of: determining that a terminal device is to start a session for a certain service, the service using a reception frequency; based on that determination, changing at least one cell selection and/or re-selection parameter in respect of the terminal device with the effect that a subsequent cell selection and/or re-selection performed by the device would favor cells that use the reception frequency used in the service session over other cells.
Type:
Grant
Filed:
September 8, 2004
Date of Patent:
October 30, 2012
Assignee:
Core Wireless Licensing S.A.R.L.
Inventors:
Sari Nielsen, Luis Barreto, Quan Tat, Kimmo Kettunen, Jussi Numminen
Abstract: The present invention discloses a hand and press-button dual-way manual pulse generator with built-in indicator lamps, which comprises a rotation pulse input unit and a CPU. The CPU is connected with a forward rotation indicator lamp and an inverse rotation indicator lamp. The rotation signal input unit and/or the press-button signal input unit transmit the output signal to the CPU. The rotation pulse input unit transmits the output signal to the CPU where the output signal is processed and the control signal is then output through the difference chip. Meanwhile, the CPU collects control signals through the feedback circuit to realize self-check when the machine is turned on. The pulse generator has a non-contact structure extending significantly its service life than the prior art, which makes it durable.
Abstract: A method for electrostatic coating of medical devices such as stents and balloons is described. The method includes applying a composition to a polymeric component of a medical device which has little or no conductivity. The polymeric component could be a material from which the body or a strut of the stent is made or could be a polymeric coating pre-applied on the stent. The polymeric component could be the balloon wall. A charge can then be applied to the polymeric component or the polymeric component can be grounded. Charged particles of drugs, polymers, biobeneficial agents, or any combination of these can then be electrostatically deposited on the medical device or the coating on the medical device. One example of the composition is iodine, iodine, iodide, iodate, a complex or salt thereof which can also impart imaging capabilities to the medical device.